Efficacy and safety of mirogabalin for the treatment of fibromyalgia: results from three 13-week randomized, double-blind, placebo- and active-controlled, parallel-group studies and a 52-week open-label extension study

Volume: 35, Issue: 10, Pages: 1825 - 1835
Published: Jul 9, 2019
Abstract
Lesley M. Arnolda, Susan Whitakerb, Ching Hsub, David Jacobsb & Domenico Merantec*a Women’s Health Research Program, University of Cincinnati College of Medicine, Cincinnati, OH, USA; b Daiichi Sankyo Inc., Basking Ridge, NJ, USA; c Global Clinical Development, Daiichi Sankyo Development, Gerrards Cross, United...
Paper Details
Title
Efficacy and safety of mirogabalin for the treatment of fibromyalgia: results from three 13-week randomized, double-blind, placebo- and active-controlled, parallel-group studies and a 52-week open-label extension study
Published Date
Jul 9, 2019
Volume
35
Issue
10
Pages
1825 - 1835
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.